Phase II trial to investigate efficacy and safety of bendamustine,dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

按检索

Phase II trial to investigate efficacy and safety of bendamustine,dexamethasone and thalidomide in relapsed or refractory multiple myeloma patients after treatment with lenalidomide and bortezomib

Authors:	Michael Mian Norbert Pescosta Stefania Badiali Paola Cristina Cappelletto Luigi Marcheselli Stefano Luminari Francesca Patriarca Renato Zambello Anna Pascarella Giuseppe Tagariello Alessandra Marabese Patrizia Mondello Atto Billio Sergio Cortelazzo

Institution:	1. Department of Haematology & CBMT, Hospital of Bolzano, Bolzano, Italy;2. Fondazione Italiana LInfomi, Modena and Alessandria, Italy;3. Hospital Pharmacy, Hospital of Bolzano, Bolzano, Italy;4. Haematology, Santa Maria Nuova Hospital, IRCCS, Reggio Emilia, Italy;5. ClinicaEmatologica e Unita' di TerapieCellulari “Carlo Melzi”, Azienda Ospedaliera-Universitaria, Udine, Italy;6. Padua University School of Medicine, Padova, Italy;7. U.O. Ematologia, Ospedaledell'Angelo, Venezia-Mestre, Italy;8. Transfusion Service, Haemophilia Centre and Haematology, Laboratory Analysis, Castelfranco Veneto Hospital, Castelfranco Veneto, Italy;9. Department of Human Pathology, University of Messina, Messina, Italy;10. Humanitas/Gavazzeni Cancer Center, Bergamo, Italy

Abstract:

Keywords:	myeloma bendamustine thalidomide dexametasone refractory